Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins

被引:73
作者
Freedland, SJ
Terris, MK
Presti, JC
Amling, CL
Kane, CJ
Trock, B
Aronson, WJ
机构
[1] Johns Hopkins Sch Med, Dept Urol, Baltimore, MD 21287 USA
[2] Med Coll Georgia, Urol Sect, Augusta, GA USA
[3] Stanford Univ, Sch Med, Dept Urol, Palo Alto, CA USA
[4] San Diego Naval Hosp, Dept Urol, San Diego, CA USA
[5] Univ Calif San Francisco, Sch Med, Dept Urol, San Francisco, CA USA
[6] Vet Adm Med Ctr, Dept Surg, Urol Sect, San Francisco, CA USA
[7] Univ Calif Los Angeles, Sch Med, Dept Surg, Vet Adm Greater Los Angeles Healthcare Syst, Los Angeles, CA USA
[8] Univ Calif Los Angeles, Sch Med, Dept Urol, Los Angeles, CA USA
关键词
prostatic neoplasms; prostatectomy; obesity; African Americans;
D O I
10.1097/01.ju.0000135302.58378.ae
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Purpose: We have previously shown that men with a body mass index (BMI) greater than 35 kg/m(2) had higher rates of positive surgical margins and significantly higher biochemical recurrence rates following radical prostatectomy (RP). To determine whether the higher prostate specific antigen (PSA) recurrence rates were due solely to the higher positive margin rate, we examined whether obesity was an independent predictor of biochemical failure among men with negative surgical margins. Materials and Methods: We examined data from 1,250 men treated with RP between 1988 and 2003 at 5 equal access medical centers, of whom 731 had pathologically organ confined disease and negative surgical margins. Multivariate Cox proportional hazards analysis was used to determine if BMI was a significant independent predictor of biochemical recurrence. Results: Mean BMI significantly increased over time (p = 0.010). Black men were significantly more likely to be obese than white or nonwhite-nonblack men. After controlling for all preoperative characteristics, body mass index was a significant predictor of biochemical failure with moderately and severely obese men (BMI 35 kg/m(2) or greater) having greater than a 4-fold increased risk of PSA failure (p = 0.035). After controlling for the higher pathological Gleason grades among obese men, body mass index remained a significant predictor of biochemical failure with moderately and severely obese men (BMI 35 kg/m(2) or greater) having nearly a 4-fold increased risk for PSA failure (p = 0.036). Conclusions: BMI 35 kg/m(2) or greater was associated with higher grade tumors and worse outcome following RP in a cohort of men with favorable pathological findings. Thus, surgical technique (margin status) cannot fully explain the worse outcomes among obese men, suggesting that obesity may be associated with a biologically more aggressive form of prostate cancer.
引用
收藏
页码:520 / 524
页数:5
相关论文
共 20 条
[1]
Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy [J].
Amling, CL ;
Riffenburgh, RH ;
Sun, L ;
Moul, JW ;
Lance, RS ;
Kusuda, L ;
Sexton, WJ ;
Soderdahl, DW ;
Donahue, TF ;
Foley, JP ;
Chung, AK ;
McLeod, DG .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (03) :439-445
[2]
Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy [J].
Amling, CL ;
Kane, CJ ;
Riffenburgh, RH ;
Ward, JF ;
Roberts, JL ;
Lance, RS ;
Friedrichs, PA ;
Moul, JW .
UROLOGY, 2001, 58 (05) :723-728
[3]
The underlying basis for obesity: Relationship to cancer [J].
Bray, GA .
JOURNAL OF NUTRITION, 2002, 132 (11) :3451S-3455S
[4]
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults [J].
Calle, EE ;
Rodriguez, C ;
Walker-Thurmond, K ;
Thun, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (17) :1625-1638
[5]
CastroMagana M, 1996, J ANDROL, V17, P516
[6]
Prevalence and trends in obesity among US adults, 1999-2000 [J].
Flegal, KM ;
Carroll, MD ;
Ogden, CL ;
Johnson, CL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (14) :1723-1727
[7]
Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: A report by the shared equal access regional cancer hospital database study group [J].
Freedland, SJ ;
Aronson, WJ ;
Kane, CJ ;
Presti, JC ;
Amling, CL ;
Elashoff, D ;
Terris, MK .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (03) :446-453
[8]
Race as an outcome predictor after radical prostatectomy: Results from the shared equal access regional cancer hospital (search) database [J].
Freedland, SJ ;
Amling, CL ;
Dorey, F ;
Kane, CJ ;
Presti, JC ;
Terris, MK ;
Aronson, WJ .
UROLOGY, 2002, 60 (04) :670-674
[9]
EFFECT OF FINASTERIDE, A 5-ALPHA-REDUCTASE INHIBITOR ON PROSTATE TISSUE ANDROGENS AND PROSTATE-SPECIFIC ANTIGEN [J].
GELLER, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 71 (06) :1552-1555
[10]
GIOVANNUCCI E, 2003, J NATL CANCER I, V95, P12450